Recuro Health Announces Its $15 Million Series A Round Led by ARCH Venture Partners: Funds Additional Acquisitions Expanding Digital Health Solutions Capabilities, Increased Marketing, Company Growth

Teladoc Founder’s Startup Brings Patient Monitoring Home

A Conversation with Michael Brombach, Chief Product Officer at Recuro Health and founder of SupDoc

Delta Variant, Stalled Vaccination Rates, New Directives from Federal/State Governments, CDC and Employers Increase Demand for Recuro’s At-Home & In-office COVID Testing Solution

Spotlight Interview: John Halsey, Chief Growth Officer, Recuro & Michael Brombach, Executive Director, Recuro

Recuro’s At-Home Testing Expert Shares “Best Practices” and Industry Future at American Telemedicine Association’s 2021 Conference

Recuro Acquires Genomics Risk Stratification Tool: Expanding Capabilities for Personalized Care and Streamlining Full Continuum of Care

Recuro Health Integrated Solutions Platform Supports Employers, Payers, Government Manage Population Health Post COVID: Featured at HHS RADx Summit

Recuro Health’s Digital Solutions Promote Integration of Behavioral and Physical Health, More Personalized and Convenient Care

Recuro Health Further Expands Digital Solution Platform: Acquires My Legacy Decision Support App, Integrates Genetic Profiles to Enhance Disease Management & Care Coordination